Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2009 2
2010 1
2011 3
2013 1
2014 1
2015 1
2018 1
2019 1
2020 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Fast effectiveness of a solubilized low-dose budesonide nasal spray in allergic rhinitis.
Zieglmayer P, Schmutz R, Lemell P, Unger-Manhart N, Nakowitsch S, Goessl A, Savli M, Zieglmayer R, Prieschl-Grassauer E. Zieglmayer P, et al. Among authors: nakowitsch s. Clin Exp Allergy. 2020 Sep;50(9):1065-1077. doi: 10.1111/cea.13691. Epub 2020 Jul 7. Clin Exp Allergy. 2020. PMID: 32569395 Free PMC article. Clinical Trial.
Saponin Micelles Lead to High Mucosal Permeation and In Vivo Efficacy of Solubilized Budesonide.
Nakowitsch S, Koller C, Seifert JM, König-Schuster M, Unger-Manhart N, Siegl C, Kirchoff N, Foglar E, Graf C, Morokutti-Kurz M, Neurath M, Sladek S, Knecht C, Sipos W, Prieschl-Grassauer E, Grassauer A. Nakowitsch S, et al. Pharmaceutics. 2020 Sep 5;12(9):847. doi: 10.3390/pharmaceutics12090847. Pharmaceutics. 2020. PMID: 32899549 Free PMC article.
Antimycotic-antibiotic amphotericin B promotes influenza virus replication in cell culture.
Roethl E, Gassner M, Krenn BM, Romanovskaya-Romanko EA, Seper H, Romanova J, Nakowitsch S, Sturlan S, Wolschek M, Sirotkin A, Kiselev O, Muster T, Egorov A. Roethl E, et al. Among authors: nakowitsch s. J Virol. 2011 Nov;85(21):11139-45. doi: 10.1128/JVI.00169-11. Epub 2011 Aug 17. J Virol. 2011. PMID: 21849438 Free PMC article.
Development of a live-attenuated influenza B DeltaNS1 intranasal vaccine candidate.
Wressnigg N, Voss D, Wolff T, Romanova J, Ruthsatz T, Mayerhofer I, Reiter M, Nakowitsch S, Humer J, Morokutti A, Muster T, Egorov A, Kittel C. Wressnigg N, et al. Among authors: nakowitsch s. Vaccine. 2009 May 11;27(21):2851-7. doi: 10.1016/j.vaccine.2009.02.087. Epub 2009 Mar 11. Vaccine. 2009. PMID: 19366569
The Intranasal Application of Zanamivir and Carrageenan Is Synergistically Active against Influenza A Virus in the Murine Model.
Morokutti-Kurz M, König-Schuster M, Koller C, Graf C, Graf P, Kirchoff N, Reutterer B, Seifert JM, Unger H, Grassauer A, Prieschl-Grassauer E, Nakowitsch S. Morokutti-Kurz M, et al. Among authors: nakowitsch s. PLoS One. 2015 Jun 8;10(6):e0128794. doi: 10.1371/journal.pone.0128794. eCollection 2015. PLoS One. 2015. PMID: 26053018 Free PMC article.
Preclinical evaluation of a replication-deficient intranasal DeltaNS1 H5N1 influenza vaccine.
Romanova J, Krenn BM, Wolschek M, Ferko B, Romanovskaja-Romanko E, Morokutti A, Shurygina AP, Nakowitsch S, Ruthsatz T, Kiefmann B, König U, Bergmann M, Sachet M, Balasingam S, Mann A, Oxford J, Slais M, Kiselev O, Muster T, Egorov A. Romanova J, et al. Among authors: nakowitsch s. PLoS One. 2009 Jun 19;4(6):e5984. doi: 10.1371/journal.pone.0005984. PLoS One. 2009. PMID: 19543385 Free PMC article.
13 results